FS KKR Capital Corp.
FS KKR Capital Corp. (FSK) Financial Performance & Income Statement Overview
Analyze FS KKR Capital Corp. (FSK) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
FS KKR Capital Corp. (FSK) Income Statement & Financial Overview
Explore comprehensive income reports for FS KKR Capital Corp. FSK, broken down by year and quarter.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $242.00M | $295.00M | $288.00M | $230.00M |
Cost of Revenue | $108.00M | $111.00M | $118.00M | $115.00M |
Gross Profit | $134.00M | $184.00M | $170.00M | $115.00M |
Gross Profit Ratio | $0.55 | $0.62 | $0.59 | $0.50 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $9.00M | $9.00M | $10.00M | $10.00M |
Operating Expenses | $14.00M | $14.00M | $108.00M | $109.00M |
Total Costs & Expenses | $122.00M | $125.00M | $128.00M | $125.00M |
Interest Income | $302.00M | $324.00M | $356.00M | $353.00M |
Interest Expense | $108.00M | $111.00M | $118.00M | $115.00M |
Depreciation & Amortization | -$300.00M | $658.00M | -$333.00M | -$330.00M |
EBITDA | $120.00M | $170.00M | $160.00M | $105.00M |
EBITDA Ratio | $0.50 | $0.58 | $0.56 | $0.46 |
Operating Income | $120.00M | $310.00M | $160.00M | $105.00M |
Operating Income Ratio | $0.50 | $1.05 | $0.56 | $0.46 |
Other Income/Expenses (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
Income Before Tax | $120.00M | $170.00M | $160.00M | $105.00M |
Income Before Tax Ratio | $0.50 | $0.58 | $0.56 | $0.46 |
Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Net Income | $120.00M | $147.00M | $160.00M | $105.00M |
Net Income Ratio | $0.50 | $0.50 | $0.56 | $0.46 |
EPS | $0.43 | $0.52 | $0.57 | $0.37 |
Diluted EPS | $0.43 | $0.52 | $0.57 | $0.37 |
Weighted Avg Shares Outstanding | $280.07M | $280.07M | $280.07M | $280.07M |
Weighted Avg Shares Outstanding (Diluted) | $280.07M | $280.07M | $280.07M | $280.07M |
Over the past four quarters, FS KKR Capital Corp. demonstrated steady revenue growth, increasing from $230.00M in Q2 2024 to $242.00M in Q1 2025. Operating income reached $120.00M in Q1 2025, maintaining a consistent 50% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $120.00M, reflecting operational efficiency. Net income dropped to $120.00M, with EPS at $0.43. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan